{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:42:53Z","timestamp":1788846173699,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in the dystrophin gene cause Duchenne muscular dystrophy (DMD), a common muscle disease that manifests with muscle weakness, wasting, and degeneration. An emerging theme in DMD pathophysiology is an intramuscular deficit in the gasotransmitter hydrogen sulfide (H<jats:sub>2<\/jats:sub>S). Here we show that the <jats:italic>C. elegans<\/jats:italic> DMD model displays reduced levels of H<jats:sub>2<\/jats:sub>S and expression of genes required for sulfur metabolism. These reductions can be offset by increasing bioavailability of sulfur containing amino acids (L-methionine, L-homocysteine, L-cysteine, L-glutathione, and L-taurine), augmenting healthspan primarily via improved calcium regulation, mitochondrial structure and delayed muscle cell death. Additionally, we show distinct differences in preservation mechanisms between sulfur amino acid vs H<jats:sub>2<\/jats:sub>S administration, despite similarities in required health-preserving pathways. Our results suggest that the H<jats:sub>2<\/jats:sub>S deficit in DMD is likely caused by altered sulfur metabolism and that modulation of this pathway may improve DMD muscle health via multiple evolutionarily conserved mechanisms.<\/jats:p>","DOI":"10.1038\/s42003-022-04212-z","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T09:03:52Z","timestamp":1668589432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sulfur amino acid supplementation displays therapeutic potential in a C. elegans model of Duchenne muscular dystrophy"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0412-7530","authenticated-orcid":false,"given":"Rebecca A.","family":"Ellwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7660-7392","authenticated-orcid":false,"given":"Luke","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1809-7029","authenticated-orcid":false,"given":"Roberta","family":"Torregrossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi","family":"Sudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Piasecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Etheridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4425-9746","authenticated-orcid":false,"given":"Nathaniel J.","family":"Szewczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"4212_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.17305\/bjbms.2015.636","volume":"15","author":"E Le Rumeur","year":"2015","unstructured":"Le Rumeur, E. Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies. Bosn. J. Basic Med. Sci. 15, 14\u201320 (2015).","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"4212_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1152\/physrev.00028.2001","volume":"82","author":"DJ Blake","year":"2002","unstructured":"Blake, D. J. et al. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82, 291\u2013329 (2002).","journal-title":"Physiol. Rev."},{"key":"4212_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1212\/WNL.28.5.439","volume":"28","author":"JB Bodensteiner","year":"1978","unstructured":"Bodensteiner, J. B. & Engel, A. G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 28, 439\u2013446 (1978).","journal-title":"Neurology"},{"key":"4212_CR4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.mehy.2015.08.015","volume":"85","author":"CA Timpani","year":"2015","unstructured":"Timpani, C. A., Hayes, A. & Rybalka, E. Revisiting the dystrophin-ATP connection: how half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology. Med. Hypotheses 85, 1021\u20131033 (2015).","journal-title":"Med. Hypotheses"},{"key":"4212_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1177\/0883073814558120","volume":"30","author":"S Kim","year":"2015","unstructured":"Kim, S. et al. Corticosteroid treatments in males with duchenne muscular dystrophy: treatment duration and time to loss of ambulation. J. Child Neurol. 30, 1275\u20131280 (2015).","journal-title":"J. Child Neurol."},{"key":"4212_CR6","doi-asserted-by":"publisher","first-page":"R163","DOI":"10.1093\/hmg\/ddy171","volume":"27","author":"L Echevarria","year":"2018","unstructured":"Echevarria, L., Aupy, P. & Goyenvalle, A. Exon-skipping advances for Duchenne muscular dystrophy. Hum. Mol. Genet. 27, R163\u2013R172 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"4212_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s40265-021-01512-2","volume":"81","author":"M Shirley","year":"2021","unstructured":"Shirley, M. Casimersen: first approval. Drugs 81, 875\u2013879 (2021).","journal-title":"Drugs"},{"key":"4212_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0631-3","volume":"12","author":"S Ryder","year":"2017","unstructured":"Ryder, S. et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J. Rare Dis. 12, 79 (2017).","journal-title":"Orphanet J. Rare Dis."},{"key":"4212_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1242\/dmm.018424","volume":"8","author":"JW McGreevy","year":"2015","unstructured":"McGreevy, J. W. et al. Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Dis. Model Mech. 8, 195\u2013213 (2015).","journal-title":"Dis. Model Mech."},{"key":"4212_CR10","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.3390\/ijms22094891","volume":"22","author":"RA Ellwood","year":"2021","unstructured":"Ellwood, R. A., Piasecki, M. & Szewczyk, N. J. Caenorhabditis elegans as a model system for duchenne muscular dystrophy. Int J. Mol. Sci. 22, 4891 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"4212_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-021-00275-4","volume":"11","author":"L Lesanpezeshki","year":"2021","unstructured":"Lesanpezeshki, L. et al. Investigating the correlation of muscle function tests and sarcomere organization in C. elegans. Skelet. Muscle 11, 20 (2021).","journal-title":"Skelet. Muscle"},{"key":"4212_CR12","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.18632\/aging.101654","volume":"10","author":"CJ Gaffney","year":"2018","unstructured":"Gaffney, C. J. et al. Greater loss of mitochondrial function with ageing is associated with earlier onset of sarcopenia in C. elegans. Aging (Albany NY). 10, 3382\u20133396 (2018).","journal-title":"Aging (Albany NY)."},{"key":"4212_CR13","doi-asserted-by":"publisher","first-page":"e2018342118","DOI":"10.1073\/pnas.2018342118","volume":"118","author":"RA Ellwood","year":"2021","unstructured":"Ellwood, R. A. et al. Mitochondrial hydrogen sulfide supplementation improves health in the C. elegans Duchenne muscular dystrophy model. Proc. Natl Acad. Sci. USA. 118, e2018342118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"4212_CR14","doi-asserted-by":"publisher","first-page":"dmm036137","DOI":"10.1242\/dmm.036137","volume":"11","author":"JE Hewitt","year":"2018","unstructured":"Hewitt, J. E. et al. Muscle strength deficiency and mitochondrial dysfunction in a muscular dystrophy model of Caenorhabditis elegans and its functional response to drugs. Dis. Model Mech. 11, dmm036137 (2018).","journal-title":"Dis. Model Mech."},{"key":"4212_CR15","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.cmet.2019.10.007","volume":"30","author":"J Zivanovic","year":"2019","unstructured":"Zivanovic, J. et al. Selective persulfide detection reveals evolutionarily conserved antiaging effects of S-Sulfhydration. Cell Metab. 30, 1152\u20131170 (2019).","journal-title":"Cell Metab."},{"key":"4212_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ars.2017.7058","volume":"31","author":"X Cao","year":"2019","unstructured":"Cao, X. et al. A review of hydrogen sulfide synthesis, metabolism, and measurement: is modulation of hydrogen sulfide a novel therapeutic for cancer? Antioxid. Redox Signal. 31, 1\u201338 (2019).","journal-title":"Antioxid. Redox Signal."},{"key":"4212_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1146\/annurev.nutr.24.012003.132418","volume":"24","author":"MH Stipanuk","year":"2004","unstructured":"Stipanuk, M. H. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev. Nutr. 24, 539\u2013577 (2004).","journal-title":"Annu Rev. Nutr."},{"key":"4212_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bph.14446","volume":"176","author":"JI Sbodio","year":"2019","unstructured":"Sbodio, J. I., Snyder, S. H. & Paul, B. D. Regulators of the transsulfuration pathway. Br. J. Pharmacol. 176, 583\u2013593 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"4212_CR19","doi-asserted-by":"publisher","first-page":"361ra139","DOI":"10.1126\/scitranslmed.aaf5504","volume":"8","author":"D Ryu","year":"2016","unstructured":"Ryu, D. et al. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation. Sci. Transl. Med. 8, 361ra139 (2016).","journal-title":"Sci. Transl. Med."},{"key":"4212_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41514-020-0044-8","volume":"6","author":"LT Ng","year":"2020","unstructured":"Ng, L. T. et al. Lifespan and healthspan benefits of exogenous H2S in C. elegans are independent from effects downstream of eat-2 mutation. NPJ Aging Mech. Dis. 6, 6 (2020).","journal-title":"NPJ Aging Mech. Dis."},{"key":"4212_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/bj2350625","volume":"235","author":"VM Pain","year":"1986","unstructured":"Pain, V. M. Initiation of protein synthesis in mammalian cells. Biochem J. 235, 625\u2013637 (1986).","journal-title":"Biochem J."},{"key":"4212_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26254-2","volume":"8","author":"KM Mazor","year":"2018","unstructured":"Mazor, K. M. et al. Effects of single amino acid deficiency on mRNA translation are markedly different for methionine versus leucine. Sci. Rep. 8, 8076 (2018).","journal-title":"Sci. Rep."},{"key":"4212_CR23","doi-asserted-by":"publisher","first-page":"6428","DOI":"10.1093\/hmg\/ddv353","volume":"24","author":"N Brouilly","year":"2015","unstructured":"Brouilly, N. et al. Ultra-structural time-course study in the C. elegans model for Duchenne muscular dystrophy highlights a crucial role for sarcomere-anchoring structures and sarcolemma integrity in the earliest steps of the muscle degeneration process. Hum. Mol. Genet. 24, 6428\u20136445 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"4212_CR24","doi-asserted-by":"publisher","first-page":"19024","DOI":"10.1073\/pnas.1308866110","volume":"110","author":"KH Oh","year":"2013","unstructured":"Oh, K. H. & Kim, H. Reduced IGF signaling prevents muscle cell death in a Caenorhabditis elegans model of muscular dystrophy. Proc. Natl Acad. Sci. USA. 110, 19024\u201319029 (2013).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"4212_CR25","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1093\/hmg\/ddt302","volume":"22","author":"J Giacomotto","year":"2013","unstructured":"Giacomotto, J. et al. Chemical genetics unveils a key role of mitochondrial dynamics, cytochrome c release and IP3R activity in muscular dystrophy. Hum. Mol. Genet. 22, 4562\u20134578 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"4212_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.abb.2018.11.005","volume":"662","author":"H Hyatt","year":"2019","unstructured":"Hyatt, H. et al. Mitochondrial dysfunction induces muscle atrophy during prolonged inactivity: a review of the causes and effects. Arch. Biochem. Biophys. 662, 49\u201360 (2019).","journal-title":"Arch. Biochem. Biophys."},{"key":"4212_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0143-4160(95)90062-4","volume":"18","author":"N Imbert","year":"1995","unstructured":"Imbert, N. et al. Abnormal calcium homeostasis in Duchenne muscular dystrophy myotubes contracting in vitro. Cell Calcium 18, 177\u2013186 (1995).","journal-title":"Cell Calcium"},{"key":"4212_CR28","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1089\/ars.2012.4645","volume":"18","author":"G Yang","year":"2013","unstructured":"Yang, G. et al. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid. Redox Signal. 18, 1906\u20131919 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"4212_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/antiox11050801","volume":"11","author":"D Matuz-Mares","year":"2022","unstructured":"Matuz-Mares, D. et al. Mitochondrial calcium: effects of its imbalance in disease. Antioxidants (Basel) 11, 801 (2022).","journal-title":"Antioxidants (Basel)"},{"key":"4212_CR30","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1021\/acschembio.8b00463","volume":"13","author":"V Vitvitsky","year":"2018","unstructured":"Vitvitsky, V. et al. Cytochrome c reduction by H2S potentiates sulfide signaling. ACS Chem. Biol. 13, 2300\u20132307 (2018).","journal-title":"ACS Chem. Biol."},{"key":"4212_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.phrs.2016.08.023","volume":"113","author":"K Modis","year":"2016","unstructured":"Modis, K. et al. S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics. Pharm. Res. 113, 116\u2013124 (2016).","journal-title":"Pharm. Res."},{"key":"4212_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biocel.2015.07.016","volume":"66","author":"JR Terrill","year":"2015","unstructured":"Terrill, J. R., Grounds, M. D. & Arthur, P. G. Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy. Int J. Biochem. Cell Biol. 66, 141\u2013148 (2015).","journal-title":"Int J. Biochem. Cell Biol."},{"key":"4212_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/296165a0","volume":"296","author":"MJ Rennie","year":"1982","unstructured":"Rennie, M. J. et al. Effects of Duchenne muscular dystrophy on muscle protein synthesis. Nature 296, 165\u2013167 (1982).","journal-title":"Nature"},{"key":"4212_CR34","doi-asserted-by":"publisher","first-page":"647010","DOI":"10.3389\/fphys.2021.647010","volume":"12","author":"S Mareedu","year":"2021","unstructured":"Mareedu, S. et al. Abnormal calcium handling in duchenne muscular dystrophy: mechanisms and potential therapies. Front. Physiol. 12, 647010 (2021).","journal-title":"Front. Physiol."},{"key":"4212_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.trsl.2018.09.004","volume":"204","author":"A Mele","year":"2019","unstructured":"Mele, A. et al. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice. Transl. Res. 204, 82\u201399 (2019).","journal-title":"Transl. Res."},{"key":"4212_CR36","doi-asserted-by":"publisher","first-page":"101223","DOI":"10.1016\/j.redox.2019.101223","volume":"24","author":"M Jakaria","year":"2019","unstructured":"Jakaria, M. et al. Taurine and its analogs in neurological disorders: focus on therapeutic potential and molecular mechanisms. Redox Biol. 24, 101223 (2019).","journal-title":"Redox Biol."},{"key":"4212_CR37","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/nu12092847","volume":"12","author":"T Qaradakhi","year":"2020","unstructured":"Qaradakhi, T. et al. The anti-inflammatory effect of taurine on cardiovascular disease. Nutrients 12, 2847 (2020).","journal-title":"Nutrients"},{"key":"4212_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biopha.2003.11.005","volume":"58","author":"DM Townsend","year":"2004","unstructured":"Townsend, D. M., Tew, K. D. & Tapiero, H. Sulfur containing amino acids and human disease. Biomed. Pharmacother. 58, 47\u201355 (2004).","journal-title":"Biomed. Pharmacother."},{"key":"4212_CR39","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1039\/C5MD00170F","volume":"6","author":"BE Alexander","year":"2015","unstructured":"Alexander, B. E. et al. Investigating the generation of hydrogen sulfide from the phosphonamidodithioate slow-release donor GYY4137. Med. Chem. Commum. 6, 1649\u20131655 (2015).","journal-title":"Med. Chem. Commum."},{"key":"4212_CR40","first-page":"28","volume":"5","author":"S Le Trionnaire","year":"2015","unstructured":"Le Trionnaire, S. et al. The synthesis and functional evaluation of a mitochondria-targeted hydrogen sulfide donor, (10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5-yl)- phenoxy)decyl)triphenylphosphonium bromide (AP39). Med. Chem. Commum. 5, 28\u2013736 (2015).","journal-title":"Med. Chem. Commum."},{"key":"4212_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254 (1976).","journal-title":"Anal. Biochem."},{"key":"4212_CR42","doi-asserted-by":"publisher","first-page":"pdb.prot5439","DOI":"10.1101\/pdb.prot5439","volume":"6","author":"DC Rio","year":"2010","unstructured":"Rio, D. C. et al. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb. Protoc. 6, pdb.prot5439 (2010).","journal-title":"Cold Spring Harb. Protoc."},{"key":"4212_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ng1140","volume":"34","author":"J Reboul","year":"2003","unstructured":"Reboul, J. et al. C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression. Nat. Genet. 34, 35\u201341 (2003).","journal-title":"Nat. Genet."},{"key":"4212_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0378-1119(00)00579-5","volume":"263","author":"L Timmons","year":"2001","unstructured":"Timmons, L., Court, D. L. & Fire, A. Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene 263, 103\u2013112 (2001).","journal-title":"Gene"},{"key":"4212_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/jimd.12345","volume":"44","author":"BC Fox","year":"2021","unstructured":"Fox, B. C. et al. The mitochondria-targeted hydrogen sulfide donor AP39 improves health and mitochondrial function in a C. elegans primary mitochondrial disease model. J. Inherit. Metab. Dis. 44, 367\u2013375 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"key":"4212_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.mito.2009.11.003","volume":"10","author":"S Dingley","year":"2010","unstructured":"Dingley, S. et al. Mitochondrial respiratory chain dysfunction variably increases oxidant stress in Caenorhabditis elegans. Mitochondrion 10, 125\u2013136 (2010).","journal-title":"Mitochondrion"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04212-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04212-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04212-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T11:03:25Z","timestamp":1668769405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04212-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4212"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-04212-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"13 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.W. and R.T. have intellectual property (patents awarded and pending) on slow-release sulfide-generating molecules and their therapeutic use. M.W. is CSO of Mito<sup>Rx<\/sup> Therapeutics, Oxford, U.K. R.A.E, L.S., J.L., M.P., S.S., T.E. and N.J.S. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1255"}}